| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |